Pathway reports
Methylation and detox pathways: how well your body converts folate and B12, recycles homocysteine, and clears toxins.
EVA™ screens more than 200 million genetic variants through OmicsEdge and delivers 14 reports across five categories, from methylation and detox pathways to inherited cancer and medication response.

Every report reads what it analyses, why it matters, and the EVA™ action taken when significant variants are found.
Methylation and detox pathways: how well your body converts folate and B12, recycles homocysteine, and clears toxins.
Inherited risk aggregated across seven cancer types, each read from hundreds of thousands of variants.
How your variants affect the metabolism of common medications, predicting likely response and dosage needs.
Your genetic heritage mapped across global populations, giving context for inherited predispositions.
Brain, cardiovascular, metabolic, gut, hormone, fitness, diet, inflammation and more, plus a plain-language intro.
The most clinically significant reports, and what EVA™ does when meaningful variants are identified.
Reads eight genes controlling folate conversion, B12 absorption, homocysteine recycling and neurotransmitter clearance.
Assesses Phase I and Phase II liver detoxification, how efficiently you process toxins, medications and waste.
Aggregates inherited risk across colorectal, prostate, breast, ovarian, lung, melanoma and pancreatic cancers.
Predicts how you metabolise cardiovascular, psychiatric, pain and other drug classes, and your adverse-reaction risk.
Evaluates cognitive resilience and Alzheimer's risk, including full ApoE genotyping with clear risk tiers.
Weighs inherited risk for coronary artery disease and stroke against more than a million variants each.
Examines predispositions to insulin resistance, Type 2 diabetes and energy-metabolism efficiency.
Reads your genetic response to carbohydrates, fats and protein, plus sensitivity risk for lactose, gluten and more.
Examines muscle fibre type, VO2 max potential, recovery rate and injury susceptibility.
Methylation underpins DNA repair, detoxification, neurotransmitter synthesis and homocysteine control. Each gene is reported as normal, slightly impaired, or significantly impaired.
Converts folate into its active form for DNA repair and homocysteine recycling. The most clinically significant methylation gene, with variants in roughly 40% of people.
Regulates absorption of natural folate from food, so variants reduce dietary folate even on a folate-rich diet.
Converts synthetic folic acid into active folate inside cells. Variants mean standard folic acid is poorly used.
Recycles homocysteine back into methionine, a key control point for homocysteine levels.
Regenerates the active B12 that MTR needs, so variants stall the cycle even when B12 looks adequate.
Controls B12 absorption from the gut, so variants cause poor uptake regardless of intake.
Activates Vitamin B6 into its functional form for homocysteine metabolism and neurotransmitter synthesis.
Controls the breakdown of dopamine, adrenaline and oestrogen, shaping the stress response and oestrogen exposure.
The Alzheimer's result in the Brain Health report is driven by your ApoE genotype. EVA™ shows your allele pair and applies one of three tiers. This is a measure of genetic predisposition, not a diagnosis.
No E4 allele present.
One copy of the E4 allele.
Two copies of the E4 allele.
The complete EVA™ DNA library across five categories. Tap a category to expand it.
Join the EVA™ waitlist and be first when the app launches in Dubai.
No payment now. We'll be in touch with foundation-access details via WhatsApp, SMS, and email.
By joining, you agree to be contacted by Elite Vita about EVA™ early access via email, SMS, and WhatsApp. Your data is stored in the UAE under PDPL.
Form to be replaced with GHL embed on production. Field names and styling are GHL-compatible.